A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME)
Clinical trial NCT04603937 · TERMINATED
Trial details
- NCT number
- NCT04603937
- Sponsor
- Kodiak Sciences Inc
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-30
- Primary completion
- 2023-04-27
- Enrollment
- 459
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.